Selective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38alpha in vitro). Displays approximately 10-fold selectivity for p38alpha over p38beta and 2000-fold selectivity for p38alpha over 20 other kinases. Reduces p38alpha phosphorylation in multiple myeloma cells in vi
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted